Gloom & Doom? No. But Short Healthcare On #ACATaper

Gloom & Doom? No. But Short Healthcare On #ACATaper - stormy

Pick your poison. Whether we’re talking about Fed rate hikes, leverage, slowing utilization or job openings, all spell trouble for Healthcare.

INSTANT INSIGHT | An Update On Spain, The ECB & #EuropeImploding

Takeaway: Spanish political drama leaves investors in the dark. Meanwhile, we suggest investors continue to fade the easy yet ineffectual ECB policy.

INSTANT INSIGHT | An Update On Spain, The ECB & #EuropeImploding - Spain cartoon 06.30.2016

And the political pain continues in Spain.


The latest update is acting PM Rajoy has once again convoluted the road to forming a government, this time going against his word to evaluate a series of reform demands from the centrist Ciudadanos party (which if agreed to by Rajoy would increase the likelihood of Ciudadanos joining Rajoy’s party to form a coalition government). Will this political indecision continue, leaving investors in the dark? 


You bet!


It has been for some time. Take a look at the Spanish IBEX's performance below.


INSTANT INSIGHT | An Update On Spain, The ECB & #EuropeImploding - spain bubble peak


On a related note, ECB Minutes from July 21 show continued use of phrase “it [ECB] would act by using all instruments available within its mandate.” We continue to fade the ECB policy stance that QE will fix the region’s underlying growth and inflation ails. Our short bias on the EUR/USD remains intact.



***Editor's Note: The snippet above is from a note written by our Macro team and sent to subscribers this morning. Click here to learn more.

Daily Market Data Dump: Thursday

Takeaway: A closer look at global macro market developments.

Editor's Note: Below are complimentary charts highlighting global equity market developments, S&P 500 sector performance, volume on U.S. stock exchanges, rates and bond spreads, key currency crosses, and commodities. It's on the house. For more information on how Hedgeye can help you better understand the markets and economy (and stay ahead of consensus) check out our array of investing products




Daily Market Data Dump: Thursday - equity markets 8 18


Daily Market Data Dump: Thursday - sector performance 8 18


Daily Market Data Dump: Thursday - volume 8 18


Daily Market Data Dump: Thursday - rates and spreads 8 18


Daily Market Data Dump: Thursday - currencies 8 18


Daily Market Data Dump: Thursday - commodities 8 18

Attention Students...

Get The Macro Show and the Early Look now for only $29.95/month – a savings of 57% – with the Hedgeye Student Discount! In addition to those daily macro insights, you'll receive exclusive content tailor-made to augment what you learn in the classroom. Must be a current college or university student to qualify.

CHART OF THE DAY: A Deep Dive Into Emerging Markets

Editor's Note: Below is a brief excerpt and chart from today's Early Look written by Hedgeye Senior Macro analyst Darius Dale. Click here to learn more.


"For brevity’s sake, however, we’ll focus on one quick and dirty way to accomplish this, which is by regressing dollar-denominated equity market returns off of their respective YTD lows vs. the delta in composite PMI readings off of their respective YTD lows.


Does the market improvement match the economic improvement? If not, what is the probability the latter catches up to the former?


Regressing the aforementioned factors across the 16 emerging market economies we could find with available data yielded a positive correlation of +0.87. Even excluding outliers Brazil and Russia yielded a positively-sloping regression line with a correlation of +0.35 (see: Chart of the Day below for visualization)."


CHART OF THE DAY: A Deep Dive Into Emerging Markets - 8 18 16 Chart of the Day

Cartoon of the Day: Yield

Cartoon of the Day: Yield - Euro Zone cartoon 08.17.2016


In the past year, other than the U.K.'s FTSE, European equity market drawdowns range from the German DAX's -3% to -29% for Italy's FTSE MIB.


Allscripts: Short More | $MDRX

Allscripts: Short More | $MDRX - mdrx

This is an institutional research note on Allscripts (MDRX) written by Hedgeye Healthcare analysts Tom Tobin and Andrew Freedman on August 5th. Shares of MDRX are down -14.5% since our Healthcare team wrote "Short More." But this short still has juice left. Continue reading to understand why Tobin and Freedman see an additional -35% downside from here. 

Hedgeye Statistics

The total percentage of successful long and short trading signals since the inception of Real-Time Alerts in August of 2008.

  • LONG SIGNALS 80.33%
  • SHORT SIGNALS 78.49%